Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

United BioPharma Starts Taiwan-China Trial of Herpes Treatment

publication date: Oct 19, 2021

United BioPharma, a Taiwan-China company, will start a clinical trial of its novel long-acting treatment for genital herpes caused by simplex viruses 1 and 2 (HSV 1 and HSV2). The company will conduct the trial together with the Shanghai Public Health Clinical Centre and Taiwan's Cheng Kung University's Department of Microbiology and Immunology. UB-621, administered via subcutaneous injection, targets surface glycoprotein gD, which has been shown to inhibit viral entry into cells. The trial will serve as a basis for a China-US Phase II trial of the candidate. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital